PPH vs. DXSE.DE

Last updated Apr 2, 2026

Compare and contrast key facts about VanEck Vectors Pharmaceutical ETF (PPH) and Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE).

PPH and DXSE.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011. DXSE.DE is a passively managed fund by Xtrackers that tracks the performance of the MSCI Europe Health Care ESG Screened 20-35. It was launched on Jun 26, 2007. Both PPH and DXSE.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

PPH vs. DXSE.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Vectors Pharmaceutical ETF (PPH) and Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE). The values are adjusted to include any dividend payments, if applicable.

PPH vs. DXSE.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
PPH VanEck Vectors Pharmaceutical ETF	2.25%	22.00%	8.05%	6.95%	2.64%	17.79%	5.49%	19.39%	-5.89%	15.23%
DXSE.DE Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C	-2.48%	18.51%	-1.46%	13.03%	-10.94%	15.83%	7.64%	30.09%	-5.66%	19.19%

Different Trading Currencies

PPH is traded in USD, while DXSE.DE is traded in EUR. To make them comparable, the DXSE.DE values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, PPH achieves a 2.25% return, which is significantly higher than DXSE.DE's -2.48% return. Over the past 10 years, PPH has outperformed DXSE.DE with an annualized return of 8.21%, while DXSE.DE has yielded a comparatively lower 7.26% annualized return.

PPH

• 1D: 1.55%
• 1M: -4.34%
• YTD: 2.25%
• 6M: 12.24%
• 1Y: 20.59%
• 3Y*: 13.02%
• 5Y*: 10.93%
• 10Y*: 8.21%

DXSE.DE

• 1D: 1.59%
• 1M: -5.37%
• YTD: -2.48%
• 6M: 2.90%
• 1Y: 9.78%
• 3Y*: 6.83%
• 5Y*: 6.38%
• 10Y*: 7.26%

*Multi-year figures are annualized to reflect compound growth (CAGR)

PPH vs. DXSE.DE - Expense Ratio Comparison

PPH has a 0.36% expense ratio, which is higher than DXSE.DE's 0.17% expense ratio.

PPH

VanEck Vectors Pharmaceutical ETF

DXSE.DE

Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C

Return for Risk

PPH vs. DXSE.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PPH

PPH Risk / Return Rank: 56
PPH Sharpe Ratio Rank: 58
PPH Sortino Ratio Rank: 58
PPH Omega Ratio Rank: 50
PPH Calmar Ratio Rank: 68
PPH Martin Ratio Rank: 47

DXSE.DE

DXSE.DE Risk / Return Rank: 15
DXSE.DE Sharpe Ratio Rank: 14
DXSE.DE Sortino Ratio Rank: 14
DXSE.DE Omega Ratio Rank: 14
DXSE.DE Calmar Ratio Rank: 17
DXSE.DE Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PPH vs. DXSE.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PPH	DXSE.DE	Difference
Sharpe ratio Return per unit of total volatility	1.06	0.44	+0.62
Sortino ratio Return per unit of downside risk	1.55	0.75	+0.80
Omega ratio Gain probability vs. loss probability	1.20	1.10	+0.10
Calmar ratio Return relative to maximum drawdown	1.81	0.75	+1.06
Martin ratio Return relative to average drawdown	4.66	2.20	+2.46
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PPH vs. DXSE.DE - Sharpe Ratio Comparison

The current PPH Sharpe Ratio is 1.06, which is higher than the DXSE.DE Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of PPH and DXSE.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	PPH	DXSE.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.06	0.44	+0.62
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.74	0.35	+0.39
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.49	0.42	+0.06
Sharpe Ratio (All Time) Calculated using the full available price history	0.31	0.36	-0.05

Correlation

The correlation between PPH and DXSE.DE is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

PPH vs. DXSE.DE - Dividend Comparison

PPH's dividend yield for the trailing twelve months is around 2.06%, while DXSE.DE has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
PPH VanEck Vectors Pharmaceutical ETF	2.06%	1.78%	1.98%	2.09%	1.55%	1.62%	1.66%	1.77%	1.97%	1.92%	2.43%	1.93%
DXSE.DE Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

PPH vs. DXSE.DE - Drawdown Comparison

The maximum PPH drawdown since its inception was -51.45%, which is greater than DXSE.DE's maximum drawdown of -41.45%. Use the drawdown chart below to compare losses from any high point for PPH and DXSE.DE.

Drawdown Indicators

	PPH	DXSE.DE	Difference
Max Drawdown Largest peak-to-trough decline	-51.45%	-34.30%	-17.15%
Max Drawdown (1Y) Largest decline over 1 year	-10.02%	-14.06%	+4.04%
Max Drawdown (5Y) Largest decline over 5 years	-20.26%	-28.10%	+7.84%
Max Drawdown (10Y) Largest decline over 10 years	-29.70%	-28.10%	-1.60%
Current Drawdown Current decline from peak	-5.56%	-13.22%	+7.66%
Average Drawdown Average peak-to-trough decline	-17.38%	-8.29%	-9.09%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.88%	4.82%	-0.94%

Volatility

PPH vs. DXSE.DE - Volatility Comparison

The current volatility for VanEck Vectors Pharmaceutical ETF (PPH) is 5.24%, while Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) has a volatility of 5.65%. This indicates that PPH experiences smaller price fluctuations and is considered to be less risky than DXSE.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PPH	DXSE.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.24%	5.65%	-0.41%
Volatility (6M) Calculated over the trailing 6-month period	12.00%	12.92%	-0.92%
Volatility (1Y) Calculated over the trailing 1-year period	19.72%	22.32%	-2.60%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.87%	17.88%	-3.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.95%	17.05%	-0.10%